A radioimmunoassay for equilin in equine pregnancy plasma  by Park, B.K. et al.
Volume 71, number 1 FEBS LETTERS November 19 76 
A RADIOIMMUNOASSAY FOR EQUILIN IN EQUINE PREGNANCY PLASMA 
B. K. PARK, Theresa A. RANCE and P. D. G. DEAN 
Departments of Biochemistry and Veterinary Science, The University, P.O. Box 147, Liverpool L69 3BX, England 
Received 5 October 1976 
1. Introduction 
It is well known that the pregnant mare produces 
large quantities of the ring B unsaturated steroid 
equilin in addition to the classical oestrogens [ 1 ] . 
However, the precise biogenesis of this unusual 
steroid remains a mystery [2,3]. To facilitate a study 
of the interrelationship of the steroids present during 
equine pregnancy we decided to develop a radio- 
immunoassay for measurement of equilin in peripheral 
plasma. As equilin is thought to be a product of the 
foeto-placental unit [4] such an assay may also be of 
use as an index of foetal well-being. 
Ocstrone and equilin are present in similar concen- 
trations in equine pregnancy plasma I.51 and so it was 
important that an antiserum was produced which 
could differentiate between these two steroids. We 
therefore synthesised an antigen in which equilin was 
linked to a protein carrier through the 17-position, in 
order that the C7-Ca double bond might be fully 
exposed for immunogenic recognition. This stratagem 
proved successful as the antiserum obtained gave a 
cross-reaction of only 7.3% for oestrone. 
The use of a radioimmunoassay incorporating this 
antiserum is demonstrated by measuring equilin 
concentrations in plasma samples taken from a mare 
at weekly intervals from day 60 of pregnancy through 
to parturition. The corresponding oestrone concentra- 
tions are also recorded and demonstrate the validity 
of the equilin assay in this situation. 
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Present address: Department of Pharmacology and Thera- 
peutics, The University, P.O. Box 147, Liverpool L69 3BX, 
England. 
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2. Materials and methods 
2.1. Reagents 
Equilin, 17cw-dihydroequilin, equilenin, 17a-dihydro- 
equilenin and 17/3-dihydroequilenin were obtained 
from Ayerst, McKenna and Harrison (Montreal, 
Canada). 7a-Hydroxydehydroepiandrosterone was a 
gift from the MRC Reference Collection and all other 
steroids were purchased from Steraloids Inc. Wilton, 
USA. General reagents were purchased from BDH and 
all solvents were redistilled prior to use. Freunds 
complete adjuvant was obtained from Difco Labora- 
tories and Helix pomatia enzyme from IBF, Paris, 
France. 
2.2. Preparation of antigen 
A solution of equilin (0.17 g) and decarboxymethoxyl- 
amine hemihydrochloride (0.17 g) in anhydrous 
pyridine (8 ml) was stirred at 20°C for 24 h. After 
removal of the solvent under nitrogen at 37’C the 
oily residue was partitioned between ethyl acetate 
(50 ml) and water (25 ml). The aqueous phase was 
extracted with ethyl acetate (50 ml) and the combined 
organic fractions were dried (NazSo4) and concentrat- 
ed. Recrystallisation of the product from acetone 
gave cream-coloured needles (0.15 g) m.p. 128-131°C. 
a,, (Nujol), 1720 (carboxyl) and 1640 cm-’ 
(C,-C8 double bond); X,, (Tris buffer pH 8.5) 
230 and 270 nm; M’ 341 (CzeH2sN04 requires 
341). The derivatised steroid was coupled to bovine 
serum albumin [6] and the molar steroid:protein 
ratio determined spectrally to be 22: 1. 
2.3. Immunisation and characterization of antisera 
The conjugate was injected into four male 
New Zealand White rabbits, according to a previously 
described regimen [6] and the blood samples obtained 
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nine days after the second booster injection tested as 
before [6]. 
2.4. fieparation of the radioiodinated tracer 
An equilin 17(0carboxymethyl)oxime [r2’1] - 
iodohistamine conjugate was prepared using the 
general method of Hunter et al. [7]. The product was 
purified by preparative thin layer chromatography on 
a silica plate (Kieselgel F 254, Merck) developed in 
benzene/methanol (80:20; by vol). The major radio- 
active band (RF 0.36) was eluted with ethanol and 
stored at 4°C. The tracer could only be used for seven 
days after preparation. 
2.5. Radioimmunoassay 
200 ~1, 100 r_l1 or 50 ~1 serum samples, in duplicate, 
were pipetted into stoppered tubes and incubated 
with Helix pomatia enzyme (20 fi, 10 ~1 or 5 A) for 
30 min at 56°C to hydrolyse any conjugates present 
[8]. After extraction with diethyl ether (3 ml) the 
tubes were placed in an acetone-solid carbon dioxide 
mixture and the ether decanted into 12 X 75 mm 
tubes. Solvents were evaporated under nitrogen in a 
water bath at 37’C and the rest of the assay perform- 
ed as previously described [9] . 
The radioimmunoassay for total oestrone will be 
described elsewhere [lo] . 
3. Results 
Three of the rabbits injected with the antigen 
produced usable antisera and the assay characteristics 
of the most specific (with respect to their oestrone 
cross-reaction) of these are presented in table 1 and 
the cross-reactions in table 2. The standard curve was 
found to be linear between the 0.5 ng point and the 
20 ng point. The concentrations of equilin and 
oestrone in plasma samples taken at weekly intervals 
Table 2 
Cross-reactions of anti-equilin-17-BSA antiserum at a 
working dilution of 1000 : 1 
Steroid Cross-Reaction (%) 
Equilin 
17arDihydroequilin 
Equilin 
17orDihydroequilenin 
17P-Dihydroequilenin 
Oestrone 
17p-Oestradiol 
Androstenedione 
Androsterone 
Dehydroepiandrosterone 
7a-Hydroxydehydroepiandrosterone 
Testosterone 
Progesterone 
Cholesterol 
100 
13 
0.7 
0.2 
0.3 
7.3 
< 0.1 
< 0.1 
< 0.1 
< 0.1 
< 0.1 
< 0.1 
< 0.1 
< 0.1 
from day 60 of pregnancy through to parturition are 
shown in tig.1. 
4. L&cussion 
In many cases it has been found difficult to 
produce antisera capable of distinguishing between 
DAY5 0F GESTATION 
Fig.1. Concentrations of equilin and oestrone, measured by 
radioimmunoassay, from day sixty of pregnancy through to 
parturition. 
Table 1 
Intra assay coefficient of variation (2.4 ng) = 5.47% (n = 8) 
Intra assay coefficient of variation (16.0 ng) = 6.48% (n = 8) 
Inter assay coefficient of variation (2.4 ng) = 9.16% (n = 6) 
Inter assay coefficient of variation (16.0 ng) = 13.09% (n = 6) 
Sensitivity (least detectable point from zero) = 500 pg 0, = < 0.01) 
Recoveries ranged from 90.6-l 24% 
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steroids differing only by the presence of a double 
bond which has little influence on the shape of the 
steroid nuclei as a whole. For example, antisera raised 
against antigens in which testosterone was linked 
through the 3, 11 and 17 positions were unable to 
discriminate against dihydrotestosterone [ 111 . 
Similarly, we have raised antisera against dehydro- 
epiandrosterone linked through the 19-position which 
had a high cross-reaction for epiandrbsterone [9]. We 
therefore linked equilin through the 17-position in 
order to give maximum exposure to the Cy-Cs 
double bond and obtained an antiserum which could 
discriminate reasonably well against oestrone and 
almost completely against equilenin. These findings 
correlate well with the overall shapes of the three 
steroids. The cross-reaction of 13% for 17a-dihydro- 
equilin is not important as this steroid is produced 
in much smaller quantities than is equilin during 
equine pregnancy [2]. 
At present there is no method available for 
preparing tritiated equilin with the specific activity 
required for radioimmunoassay. We found that 
tritium could be introduced into the 16-position b) 
exchange with tritiated water on activated alumina 
[ 121 but the specific activity of the product was not 
high enough for immunoassay purposes. Nevertheless, 
a radioiodinated histamine conjugate proved satis- 
factory, even though a homologous system [ 131 was 
employed. Using an initial percentage bound of 80%, 
a standard curve ranging from 480 pg-20 ng was 
constructed. 
The assay system was tested by measuring total 
equilin concentrations in plasma samples taken from 
a pregnant mare and comparing them with corre- 
sponding oestrone concentrations. The results (fig.1) 
show that oestrone has little effect on the equilin 
concentrations measured, despite a cross-reaction of 
7.3%. The general pattern of oestrone and equilin 
concentrations obtained are in good agreement with 
those recorded by Cox [5] using gas-liquid 
chromatography after a paper chromatographic step 
and support the theory of independent biosynthetic 
pathways for the two oestrogens [2,5]. 
In conclusion, we have developed the first radio- 
immunoassay for equilin and have used it to confirm 
that maximum concentrations of equilin and oestrone 
occur at different times during equine pregnancy. We 
are at present examining the relationship of equilin 
concentrations with those of other steroids present 
during equine pregnancy such as dehydroepian- 
drosterone. 
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